Impact of risk communication on patient’s safety during the pandemic

Author:

Zuluaga-Arias Heyde-Patricia12ORCID,Alkhakany Mayada3ORCID,Younus Manal M.45,Sefiani Houda67,Caro-Rojas Angela8,Al-Zubiedi Sameh910,Albalawi Wafi F.11,Alshammari Thamir M.121314ORCID

Affiliation:

1. Colombian Association of Pharmacovigilance, Bogotá, Colombia

2. International Society of Pharmacovigilance – LATAM Chapter, Bogotá, Colombia

3. Boehringer Ingelheim; International Society of Pharmacovigilance Patient Engagement SIG, Dubai, United Arab Emirates

4. Iraqi Pharmacovigilance Center, Ministry of Health, Baghdad, Iraq

5. International Society of Pharmacovigilance – Middle East Chapter Baghdad, Iraq

6. International Society of Pharmacovigilance – Middle East Chapter Rabat, Morocco

7. CAPM, Moroccan Pharmacovigilance Centre, Rabat WHO Collaborating Centre, Rabat, Morocco

8. Pontificia Universidad Javeriana, Bogotá, Colombia

9. International Society of Pharmacovigilance – Middle East Chapter, Amman, Jordan

10. School of Pharmacy, The University of Jordan, Amman, Jordan

11. Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia

12. Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia, 11421

13. King Saud University, Riyadh, Saudi Arabia

14. International Society of Pharmacovigilance – Middle East Chapter, Riyadh, Saudi Arabia

Abstract

More than 2 years has passed since the pandemic was declared in 2019 due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was later declared to be the pathogen causing coronavirus disease 2019 (COVID-19). During this time, many healthcare systems faced numerous challenges to control the high morbidity and mortality of the disease. Unlike previous pandemics, the actions against this pandemic started quickly on both the global and country levels. These actions were, scientifically, to study the virus as well as transmission process and to develop medications and vaccines against it. Also, we had to protect people from transmission by knowing how best to apply precautionary methods. However, there were some unexpected negative consequences of the pandemic and one of those the World Health Organization (WHO) called ‘infodemic’. This term infodemic refers to the manipulation of a population’s behavior in the assessment of information (or, more accurately, lack of assessment) related to the use of medications, particularly vaccines. Unfortunately, even with positive development in science, there was limited and often contradictory amount of information on the safety and efficacy profile of drugs and vaccines. Therefore, this made it harder for public health agencies to determine the impact of the incidence of adverse reactions and events associated with interventions such as vaccines. Hence, risk communication needs to be emphasized during any pandemic, as ignoring risk communications to different stakeholders could undermine all well-intended therapeutic interventions. Given this, it is important that the different stakeholders involved (health authorities, societies, healthcare professionals, etc.) assess the different behavioral patterns within their respective populations and propose appropriate strategies to act. Such an approach complement having risk management and communication plans for this and future pandemics. The aim of this article is to explore how information management, risk management, and risk communication during the pandemic can provide valuable lessons for the future. Plain language summary Impact of risk communication on patient’s safety during the pandemic More than 2 years have gone by since the pandemic was declared in 2019 due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many challenges have been confronted by the healthcare system during this time to control the high impact of this disease. This pandemic, unlike others that humanity has faced, is characterized by a special feature: today, we have an enormous amount of information only a click away. This situation has been of great benefit to humanity and has allowed the development of science; nevertheless, misinformation (infodemics) has been a major problem, which has revealed the behavior of the population regarding the evaluation of information (or better, lack of assessment) related to the use of medications and particularly of vaccines. Given this, it is important that the different people involved (health authorities, societies, healthcare professionals, etc.) assess the behavior and propose appropriate strategies to act and have plans for this and future pandemics. This article intends to explore from the authors’ perspective how information management, risk management, and risk communication during the pandemic can provide valuable lessons for the future.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Reference47 articles.

1. Coronavirus (Covid-19) – Última Situación. Net.tr, https://www.trt.net.tr/espanol/covid19 (accessed 23 May 2022).

2. https://pubmed.ncbi.nlm.nih.gov/32641902/

3. Paho.org, https://iris.paho.org/bitstream/handle/10665.2/52052/Factsheet-infodemic_eng.pdf

4. https://www.sciencedirect.com/science/article/pii/S1477893920302179

5. https://edition.cnn.com/2020/03/23/africa/chloroquine-trump-nigeria-intl/index.html

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3